These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 5823457)
1. Potassium penicillin G injection-(buffered). Am J Hosp Pharm; 1969 Sep; 26(9):543-4. PubMed ID: 5823457 [No Abstract] [Full Text] [Related]
2. Stability studies of penicillin products. II. Potassium penicillin G buffered tablets. BUCKWALTER FH; HOLLERAN R Antibiot Chemother (Northfield); 1953 May; 3(5):540-2. PubMed ID: 24542422 [No Abstract] [Full Text] [Related]
3. Stability studies of penicillin products. VII. Buffered potassium penicillin G powder for oral use. BUCKWALTER FH; WALSH EA Antibiot Chemother (Northfield); 1953 Oct; 3(10):1020-2. PubMed ID: 24542701 [No Abstract] [Full Text] [Related]
4. Flow-injection-chemiluminescence method for the determination of penicillin G potassium. Cao W; Yang JH; Sun CX; Zhang ZJ; Gao QF Luminescence; 2005; 20(4-5):238-42. PubMed ID: 16134206 [TBL] [Abstract][Full Text] [Related]
5. Electrical conductances of dilute aqueous solutions of sodium penicillin G, potassium penicillin G, and potassium penicillin V in the 278.15-313.15 K temperature range. Bester-Rogac M; Boncina M; Apelblat Y; Apelblat A J Phys Chem B; 2007 Oct; 111(41):11957-67. PubMed ID: 17887789 [TBL] [Abstract][Full Text] [Related]
6. Precipitates found in admixtures of potassium chloride and dextrose 5 percent in water. Kramer W; Tanja JJ; Harrison WL Am J Hosp Pharm; 1970 Jul; 27(7):548-53. PubMed ID: 5431053 [No Abstract] [Full Text] [Related]
7. Letter: Particulate matter in penicillin G potassium injection. Turco SJ; Davis NM; Bhatia R Am J Hosp Pharm; 1974 Sep; 31(9):825-6. PubMed ID: 4420020 [No Abstract] [Full Text] [Related]
12. Rejection rate of reconstituted injectable drug products. Panettieri AJ; Williams WT Am J Hosp Pharm; 1972 Apr; 29(4):294-5. PubMed ID: 5025256 [No Abstract] [Full Text] [Related]
13. Compatibility of various admixtures with secondary additives at Y-injection sites of intravenous administration sets. Part 2. Allen LV; Stiles ML Am J Hosp Pharm; 1981 Mar; 38(3):380-1. PubMed ID: 7223755 [No Abstract] [Full Text] [Related]
14. [Enzymes and drug incompatibility]. Zahnarztl Mitt; 1966 May; 56(10):471-2. PubMed ID: 5219455 [No Abstract] [Full Text] [Related]